[{"AccountsPayableCurrent_0_Q2_USD":466000.0,"NetIncomeLoss_1_Q2_USD":391303000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":391303000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":431229000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":391303000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":431229000.0,"NonoperatingIncomeExpense_1_Q2_USD":-10726000.0,"NonoperatingIncomeExpense_2_Q2_USD":-15766000.0,"OperatingIncomeLoss_1_Q2_USD":65098000.0,"OperatingIncomeLoss_2_Q2_USD":110496000.0,"OperatingLeaseCost_1_Q2_USD":630000.0,"OperatingLeaseCost_2_Q2_USD":1261000.0,"OperatingLeaseLiability_0_Q2_USD":22555000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3161000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":19394000.0,"OperatingLeasePayments_2_Q2_USD":778000.0,"NetIncomeLoss_2_Q2_USD":431229000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":122262000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":7873000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":3608000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":28942000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3129000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":3189000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3126000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3065000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1578000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":6387000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":15975000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1007218000.0,"LongTermDebt_0_Q2_USD":442007000.0,"LongTermDebtCurrent_0_Q2_USD":120700000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":126557000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0_Q2_USD":201500000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":3000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":203750000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":4500000.0,"LiabilitiesCurrent_0_Q2_USD":134370000.0,"LeaseCost_2_Q2_USD":1689000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.058,"OtherAssetsNoncurrent_0_Q2_USD":879000.0,"RestructuringReserveCurrent_0_Q2_USD":2124000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1034827000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":104031000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":192876000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":27052000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":54704000.0,"ShareBasedCompensation_2_Q2_USD":9985000.0,"ShortTermLeaseCost_1_Q2_USD":214000.0,"ShortTermLeaseCost_2_Q2_USD":428000.0,"StockholdersEquity_0_Q2_USD":511756000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":2230000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":5672000.0,"UnamortizedDebtIssuanceExpense_0_Q2_USD":5733000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":163495000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":163134000.0,"RestructuringReserveAccrualAdjustment1_2_Q2_USD":-594000.0,"RestructuringReserve_0_Q2_USD":2277000.0,"RestructuringCharges_2_Q2_USD":29000.0,"RestructuringCharges_1_Q2_USD":-282000.0,"OtherEmployeeRelatedLiabilitiesCurrent_0_Q2_USD":438000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1482000.0,"PaymentsForRestructuring_2_Q2_USD":9109000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesAuthorized_0_Q2_shares":75000000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":null,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2157000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":12320000.0,"ProfitLoss_2_Q2_USD":431229000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8105000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":12163000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":27647000.0,"RestrictedCash_0_Q2_USD":2220000.0,"RestrictedCashCurrent_0_Q2_USD":1735000.0,"RestrictedCashNoncurrent_0_Q2_USD":485000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":7873000.0,"LeaseCost_1_Q2_USD":844000.0,"InvestmentIncomeNet_2_Q2_USD":368000.0,"InvestmentIncomeNet_1_Q2_USD":172000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":492699000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":494919000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":130135000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"CommonStockSharesIssued_0_Q2_shares":162831953.0,"CommonStockSharesOutstanding_0_Q2_shares":162831953.0,"CommonStockValue_0_Q2_USD":163000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":391303000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":431229000.0,"ConvertibleDebtCurrent_0_Q2_USD":112852000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":329155000.0,"CostsAndExpenses_1_Q2_USD":38933000.0,"CostsAndExpenses_2_Q2_USD":82380000.0,"AssetsCurrent_0_Q2_USD":620268000.0,"Assets_0_Q2_USD":1007218000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":56930000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":56637000.0,"AccountsReceivableNet_0_Q2_USD":126000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":102252000.0,"AccountsReceivableNetNoncurrent_0_Q2_USD":23706000.0,"AccruedBonusesCurrent_0_Q2_USD":6879000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1283000.0,"AccruedSalariesCurrent_0_Q2_USD":972000.0,"AccruedVacationCurrent_0_Q2_USD":2400000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":542915000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1546420000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4589000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":9985000.0,"AmortizationOfDebtDiscountPremium_1_Q2_USD":5516000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":10940000.0,"AmortizationOfFinancingCosts_1_Q2_USD":412000.0,"AmortizationOfFinancingCosts_2_Q2_USD":811000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":11750000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4589000.0,"DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_0_Q2_USD":112309000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":72959000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":337800000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":94730000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-336931000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-336499000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-10428000.0,"IncreaseDecreaseInOperatingLeaseLiability_2_Q2_USD":-891000.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":-280000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-64000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":54372000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3101000.0,"InterestExpense_1_Q2_USD":7732000.0,"InterestExpense_2_Q2_USD":15358000.0,"InterestExpenseDebt_1_Q2_USD":7732000.0,"InterestExpenseDebt_2_Q2_USD":15358000.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":1804000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":3607000.0,"InterestPayableCurrent_0_Q2_USD":300000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":-19794000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":161460000.0,"HedgingLiabilitiesNoncurrent_0_Q2_USD":11061000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-17000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-337800000.0,"Depreciation_2_Q2_USD":806000.0,"EarningsPerShareBasic_1_Q2_USD":2.42,"EarningsPerShareBasic_2_Q2_USD":2.67,"EarningsPerShareDiluted_2_Q2_USD":2.64,"EarningsPerShareDiluted_1_Q2_USD":2.39,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.21,"HedgingAssetsCurrent_0_Q2_USD":11262000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"FairValueAdjustmentOfWarrants_2_Q2_USD":-1027000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2_Q2_USD":-1803000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0_Q2_USD":11262000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":1027000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":11061000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q2_USD":-3166000.0,"GainLossOnDerivativeInstrumentsNetPretax_2_Q2_USD":-776000.0,"EntityListingParValuePerShare_2_Q2_USD":0.001,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":161948000.0,"Ticker":"IRWD","CIK":"1446847","name":"IRONWOOD PHARMACEUTICALS INC","OfficialName":"Ironwood Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1913848067.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]